Peritoneal Mesothelioma » Treatment of peritoneal mesothelioma

Clinical Presentation of Peritoneal Mesothelioma

Clay Hillary — Fri, 26 Feb 2010 04:06:34 +0000

The peritoneal mesothelioma patients tend to have a strong exposure to asbestos fibers into the air. The latent period between exposure to asbestos and the onset of the disease has an average of 20-30 years. This is shorter than for pleural mesothelioma, which has a latency period of 30-40 years. A study by the Washington Cancer Institute, a leader in the treatment of peritoneal mesothelioma, showed that patients typically present with either abdominal pain (33%) or increased abdominal girth (31%). Other symptoms include hernia ion in 12%, increased abdominal girth and pain at 5%, with the remaining 19% having a variety of other clinical symptoms such as anorexia, dispend, fever and abdominal tumor. Due to the heterogeneity of these clinical symptoms, patients often do not recognize their sinister nature until too late. In advanced stages, may experience acute problems, such as intestinal obstruction, perforation or severe as cites, requiring emergency surgery. Occasionally, however, the diagnosis of peritoneal mesothelioma is incidentally during abdominal palpation and /or pelvic or laparoscopy performed for another reason.

Peritoneal Mesothelioma behaves very similar to other cancers of the peritoneal surface. This includes the peritoneal pseudomyxoma of the appendix, ovarian cancer, colorectal cancer and peritoneal sarcomatosis. Therefore, patients with these cancers of the peritoneal surface could be presented in a similar way, adding to the diagnostic problems related to vague clinical symptoms associated. Several paraneoplastic syndromes have also been reported in peritoneal mesothelioma, including hematologic disorders such as thrombocytosis, venous thrombosis, liver disease and paraneoplastic wasting syndrome.

The Facts About Peritoneal Mesothelioma

Clay Hillary — Mon, 08 Feb 2010 05:23:50 +0000

Mesothelioma is a rare form of peritoneal mesothelioma that affects about 20% of all cases of peritoneal mesothelioma. Mesothelioma tissue along the belly, is called the peritoneum hence the name of this form of cancer. The peritoneum protects the contents of the abdomen and is therefore very important to present, only one cause of peritoneal mesothelioma is known, and this is the exposure to asbestos dust and fibers Just a couple of months of exposure to asbestos without sufficient protection can lead to peritoneal mesothelioma. Thirty to fifty years later complaints by peritoneal mesothelioma are mostly elderly men who worked with asbestos decades ago when workers are not protected from asbestos dust. Many of these men are currently lodging with multiple-million-dollar lawsuits against the company exposed them to asbestos.

The asbestos fibers into the abdominal cavity can be in two different conserving species most common way they get into the abdominal cavity of them get caught in the trachea (windpipe) and bronchi (the lungs) due to mucus is swallowed and in the end from here they can through the intestinal wall into the peritoneal cavity Pass the second way in asbestos fibers may reach the peritoneum is by them lodging in the lungs. Then move into the lymphatic system and transported to the peritoneum get constant exposure to asbestos leads to a large number of fibers built into the peritoneal cavity.

The symptoms of peritoneal mesothelioma are generally only felt when the cancer has risen sharply over the symptoms are nausea, vomiting, weight loss, anorexia and abdominal pain if the cancer matures, the symptoms more severe and more severe than the symptoms of peritoneal mesothelioma. There are several treatments for peritoneal mesothelioma, although all of them have a poor success rate, the probability that a patient survives, depends on how early and aggressive treatment of cancer chemotherapy, radiation and surgery are the most commonly used Techniques for handling research on the treatment of peritoneal mesothelioma is carried out in research stations in the United States and many pharmaceutical companies.

Peritoneal Mesothelioma Information

Clay Hillary — Mon, 01 Feb 2010 05:37:29 +0000

" width="208" height="280" />

Peritoneal mesothelioma is a type of mesothelioma affects the peritoneal region of the body. The membrane abdominal mesothelium is called the peritoneum. Peritoneal Mesothelioma is a very small number of all cases of mesothelioma about 30%. We think that patients suffering from this form of mesothelioma have been exposed to asbestos at some point in the past.

The exposure period required for the necessary peritoneal mesothelioma to develop is unknown. Common symptoms include swelling in the region of the abdomen, abdominal pain, weight loss, lumps in the region of the abdomen, anemia and obstruction of small and or large intestine. Peritoneal mesothelioma patients are generally considered beyond cure.

There is no cure for the only alternative available pointing to increased life expectancy and improve quality of life of patients. Asbestos affects the peritoneum is how cells respond to the membrane fibers themselves. A thickening of the peritoneal membrane is the usual answer to these fibers.

Fluid begins to accumulate in the abdomen. Treatment of peritoneal mesothelioma include drainage of fluid in the abdomen, surgical resection is an effort to remove tumors more visible as possible. Chemotherapy and radiation therapy is sometimes combined if procedures need to be aggressive.

Theoretically, chemotherapy and radiotherapy attempts to kill rapidly dividing cells as efficiently as possible. There is also the alternative of intraperitoneal chemotherapy in these cases. The statistics on survival rates of mesothelioma is not encouraging, they range from as little as 4 months for as long as decades in exceptional cases, but normally, the survival period is 12 to 18 months. The life is largely dependent on what type of treatment undergone successful treatment and the stage where the cancer was caught. Make an accurate prediction on the success of each patient is very complicated.

Most patients, however, are mostly too far along radiotherapy and chemotherapy to be effective. At this stage, treatment is subject to two things in mind, the pain relief and extending the lifespan of patients.